Related Experiment Video
Updated: Feb 21, 2026
Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
An immunocompetent mouse model of human glioblastoma
Samantha Semenkow1, Shen Li2,3, Ulf D Kahlert4
1Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Abstract:
Orthotopic xenotransplantation studies represent the final stage in preclinical cancer research and could facilitate the implementation of precision medicine. To date, these xenografts have been tested in immunodeficient animals, but complete elimination of the adaptive immunity is a significant drawback. We present a method of efficient human glioblastoma (GBM) cell engraftment in adult mice with intact immune systems, mediated by a transient blockade of T-cell co-stimulation. Compared to transplants grown in immunodeficient hosts, the resulting tumors more accurately resemble the clinical pathophysiology of patient GBMs, which are characterized by blood-brain-barrier leakage and strong neo-vascularization. We expect our method to have great utility for studying human tumor cell biology, particularly in the field of cancer immunotherapy and in studies on microenvironmental interactions. Given the straightforward approach, the method may also be applicable to other tumor types and additional model organisms.
Insights
Researchers developed a new method for growing human glioblastoma tumors in mice with normal immune systems. This breakthrough improves preclinical cancer research and immunotherapy studies by creating more realistic tumor models.
Area of Science:
- Oncology
- Immunology
- Preclinical Research
Background:
- Orthotopic xenotransplantation is crucial for preclinical cancer research and precision medicine.
- Current models using immunodeficient animals have limitations due to the absence of adaptive immunity.
- Existing xenografts do not fully replicate the complex tumor microenvironment of human cancers.
Purpose of the Study:
- To develop an efficient method for human glioblastoma (GBM) engraftment in immunocompetent adult mice.
- To create more clinically relevant GBM xenograft models that mimic patient tumor pathophysiology.
- To enable advanced studies in cancer immunotherapy and tumor microenvironment interactions.
Main Methods:
- Transient blockade of T-cell co-stimulation to facilitate GBM cell engraftment.
- Utilizing adult mice with intact immune systems for xenotransplantation.
- Comparative analysis of xenografts grown in immunocompetent versus immunodeficient hosts.
Main Results:
- Successful and efficient engraftment of human glioblastoma cells in mice with intact immune systems.
- Xenografts in immunocompetent mice exhibit more accurate clinical pathophysiology, including blood-brain-barrier leakage and neo-vascularization.
- Demonstrated a method that overcomes the limitations of traditional immunodeficient models.
Conclusions:
- The developed method offers a more accurate preclinical model for studying human glioblastoma.
- This approach is valuable for cancer immunotherapy research and understanding tumor microenvironment interactions.
- The method's straightforward nature suggests potential applicability to other tumor types and model organisms.
